Again, I am confident next round of results will destroy the share price.
Dusko and team would have seen the cores and run preliminary tests before sending it to the lab. Based off this they chose to 1. not release the visuals and 2. not exercise their options.
1. Visuals
Clearly they are keen to release visuals of any indication of spodumene regardless of how low it is as that is what they have been doing. But they aren't here which is indicative that there isn't anything. This is a management that is KEEN to improve sentiment about Andover that would have jumped on the opportunity on the slightest indication that the results will be positive.
2. Not exercising options
If management believed the next round of results will be good that would all exercise their options to make a $$$. But they didn't which shows that they don't think it will be good results. Huge red flag.
3. Insider selling?
We know a massive holder sold their position yesterday. It may be insider information or not. Hard to tell but I think it's reasonable to assume that they saw the same red flags as above and were like "time to get out". Either way it's bad.
Another duster (which this is lining to be) will demolish the share price. In my view I'd either be bracing myself or considering an exit.
GLTAH and DYOR
RDN Price at posting:
1.2¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)